HLA-DRA Antikörper (C-Term)
Kurzübersicht für HLA-DRA Antikörper (C-Term) (ABIN453098)
Target
Alle HLA-DRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody detects HLA-DRA at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human HLA-DRA
-
-
-
-
Applikationshinweise
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000. Flow cytometry: 1: 10 - 1: 50.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.44 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA Class II DR alpha / HLA-DRA
-
Hintergrund
- HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages).Synonyms: HLA class II histocompatibility antigen DR alpha chain, HLA-DRA1, MHC class II antigen DRA
-
Molekulargewicht
- 28607 Da
-
Gen-ID
- 3122
-
NCBI Accession
- NP_061984
-
UniProt
- P01903
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-